Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $817.6M
Liabilities Breakdown FY2017
Total Liabilities: $445.5M
Asset Breakdown
Total Assets: $817.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $254.7M | 31.2% |
| Accounts Receivable | $31.1M | 3.8% |
| Inventory | $1.0M | 0.1% |
| Property, Plant & Equipment | $10.8M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $519.9M | 63.6% |
Liabilities Breakdown
Total Liabilities: $445.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.6M | 1.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $439.8M | 98.7% |